Specifically, a retrospective/prospective study involving breast cancer patients with germline BRCA1/2 mutations and normal left ventricular ejection fraction found no association between sST2 levels and left ventricular ejection fraction decline, regardless of BRCA1/2 status (30). This evidence concerns the gene BRCA1 and breast carcinoma.